Creative Biolabs-Immuno-oncology

Anti-CD47 (clone C4I7JB2E2E2E) SynExpress C-Cy3-cF-X Modified CD8+ T cells (CAT#: ITS-1224-CR1631)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD47 (clone C4I7JB2E2E2E). We employs the AAV (CMV-Cy3-c-Fos-XbaI) vector components and the SynExpress system of the lncRNA Base Editing/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CD47
Clone
C4I7JB2E2E2E
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
CMV
Effector Gene
c-Fos
Insertion Sites
XbaI
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
AAV
Transformation Accuracy
0.99
Cell Culture
Suspension Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.